Research output

  1. Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial

    Research output: Contribution to journal › Article › Academic › peer-review

  2. Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition

    Research output: Contribution to journal › Article › Academic › peer-review

  3. Favorable overall survival in stage III melanoma patients after adjuvant dendritic cell vaccination

    Research output: Contribution to journal › Article › Academic › peer-review

View all (45) »

ID: 70163